推荐对青少年进行三个疫苗接种以预防百日咳、脑膜炎球菌疾病以及由人乳头瘤病毒（HPV）引起的癌症。疾控中心分析了2022年全国青少年免疫调查中16043名年龄在13-17岁之间的青少年的数据，以评估其疫苗接种覆盖率。采用出生队列分析方法，对在13岁（即13岁生日前）和14岁（即14岁生日前）之前应该接种常规疫苗的青少年的疫苗接种覆盖率趋势进行评估，该分析是在COVID-19大流行期间之前和期间进行的。采用横断面分析方法，评估了年龄在13-17岁之间的青少年的接种覆盖率估计。在2022年，2008年出生的青少年在14岁之前的疫苗接种覆盖率仍然落后于之前的出生队列，并且在社会人口因素和卫生保健获取方式方面存在差异。2009年出生的青少年在13岁之前的疫苗接种覆盖率与COVID-19大流行前的估计相似。在所有13-17岁的青少年中，2022年的疫苗接种覆盖率水平与2021年相同；然而，在接受医疗补助的人群中，HPV疫苗系列的启动率有所下降。接种1剂破伤风、百日咳和无细胞百日咳疫苗和接种1剂脑膜炎球菌多糖结合疫苗的覆盖率较高且稳定（约为90%）。提供者应该审核青少年的疫苗接种记录，特别是那些2008年出生的青少年和符合儿童疫苗计划资格的人群，确保青少年的疫苗接种处于最新状态。

Three vaccines are routinely recommended for adolescents to prevent pertussis, meningococcal disease, and cancers caused by human papillomavirus (HPV). CDC analyzed data from the 2022 National Immunization Survey-Teen for 16,043 adolescents aged 13-17 years to assess vaccination coverage. Birth cohort analyses were conducted to assess trends in vaccination coverage by age 13 years (i.e., before the 13th birthday) and by age 14 years (i.e., before the 14th birthday) among adolescents who were due for routine vaccination before and during the COVID-19 pandemic. Cross-sectional analysis was used to assess coverage estimates among adolescents aged 13-17 years. In 2022, vaccination coverage by age 14 years among adolescents born in 2008 continued to lag that of earlier birth cohorts and varied by sociodemographic factors and access to health care compared with coverage among earlier birth cohorts. Vaccination coverage by age 13 years among adolescents born in 2009 was similar to coverage estimates obtained before the COVID-19 pandemic. Among all adolescents aged 13-17 years, 2022 vaccination coverage levels did not differ from 2021 levels; however, initiation of the HPV vaccination series decreased among those who were insured by Medicaid. Coverage with ≥1 dose of tetanus, diphtheria, and acellular pertussis vaccine and ≥1 dose meningococcal conjugate vaccine was high and stable (around 90%). Providers should review adolescent vaccination records, especially among those born in 2008 and those in populations eligible for the Vaccines for Children program, to ensure adolescents are up to date with all recommended vaccines.